Cargando…
Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affec...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706392/ https://www.ncbi.nlm.nih.gov/pubmed/26783443 http://dx.doi.org/10.1002/ccr3.458 |
_version_ | 1782409158870433792 |
---|---|
author | Whyte, Martin Quaglia, Alberto Hopkins, David |
author_facet | Whyte, Martin Quaglia, Alberto Hopkins, David |
author_sort | Whyte, Martin |
collection | PubMed |
description | Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affect how such patients are managed with insulin. |
format | Online Article Text |
id | pubmed-4706392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47063922016-01-18 Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia Whyte, Martin Quaglia, Alberto Hopkins, David Clin Case Rep Case Reports Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affect how such patients are managed with insulin. John Wiley and Sons Inc. 2015-12-01 /pmc/articles/PMC4706392/ /pubmed/26783443 http://dx.doi.org/10.1002/ccr3.458 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Whyte, Martin Quaglia, Alberto Hopkins, David Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
title | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
title_full | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
title_fullStr | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
title_full_unstemmed | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
title_short | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
title_sort | insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706392/ https://www.ncbi.nlm.nih.gov/pubmed/26783443 http://dx.doi.org/10.1002/ccr3.458 |
work_keys_str_mv | AT whytemartin insulindetemirmaybelessefficaciousinpatientswithnonalcoholicfattyliverdiseaseandhypertriglyceridemia AT quagliaalberto insulindetemirmaybelessefficaciousinpatientswithnonalcoholicfattyliverdiseaseandhypertriglyceridemia AT hopkinsdavid insulindetemirmaybelessefficaciousinpatientswithnonalcoholicfattyliverdiseaseandhypertriglyceridemia |